Clinical TrialID 5219
Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
NCT01094444
Folliculitis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5219
- Evidence Id
- 5219
- Core Evidence Id
- 5219
- Source Clinical Trial Id
- 5201
- Herb2 Clinical Trial Id
- HBCT005201
- Nct Id
- NCT01094444
- Title
- Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Folliculitis
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- OTHER: Vitamin K3
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 30
- Outcome Measure
- Potential reduction in skin toxicity by vitamin K3 lotion, Reduction in numbers of papulo-pustular eruptions in the treatment fields. Changes in follicular eruptions, dryness/redness of skin estimated by CTCAE 4.0. Patients own experience of efficacy estimated by questionaire and VAS scale., 3 months
- Sponsor Collaborator
- Per Pfeiffer
- Funded By
- OTHER
- Location
- Odense University Hospital, Odense C, 5000, Denmark
- Other Id
- 9.15
- Start Date
- 2010-05
- Primary Completion Date
- 2013-12
- Completion Date
- 2014-11
- First Posted
- 2010-03-29
- Results First Posted
- Last Update Posted
- 2020-11-16
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01094444
- Title Cn
- Title En
- Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
- Bilingual Status
- semi_complete